{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:25:47Z","timestamp":1759530347920,"version":"3.40.4"},"reference-count":67,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T00:00:00Z","timestamp":1424390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Acute lymphoblastic leukemia (<jats:styled-content style=\"fixed-case\">ALL<\/jats:styled-content>) is the most common of all paediatric cancers. Aside from predisposing to<jats:styled-content style=\"fixed-case\">ALL<\/jats:styled-content>, polymorphisms could also be associated with poor outcome. Indeed, genetic variations involved in drug metabolism could, at least partially, be responsible for heterogeneous responses to standardized leukemia treatments, hence requiring more personalized therapy. The aims of this study were to (a) to determine the prevalence of seven common genetic polymorphisms including those that affect the folate and\/or thiopurine metabolic pathways, i.e. cyclin<jats:styled-content style=\"fixed-case\">D1<\/jats:styled-content>(<jats:italic><jats:styled-content style=\"fixed-case\">CCND1<\/jats:styled-content><\/jats:italic>\u2010<jats:styled-content style=\"fixed-case\">G870A<\/jats:styled-content>), \u03b3\u2010glutamyl hydrolase (<jats:italic><jats:styled-content style=\"fixed-case\">GGH<\/jats:styled-content><\/jats:italic>\u2010<jats:styled-content style=\"fixed-case\">C452T<\/jats:styled-content>), methylenetetrahydrofolate reductase (<jats:italic><jats:styled-content style=\"fixed-case\">MTHFR<\/jats:styled-content><\/jats:italic>\u2010<jats:styled-content style=\"fixed-case\">C677T<\/jats:styled-content>and<jats:italic><jats:styled-content style=\"fixed-case\">MTHFR<\/jats:styled-content><\/jats:italic>\u2010<jats:styled-content style=\"fixed-case\">A1298C<\/jats:styled-content>), thymidylate synthase promoter (<jats:italic><jats:styled-content style=\"fixed-case\">TYMS\u2010TSER<\/jats:styled-content><\/jats:italic>), thiopurine methyltransferase (<jats:italic><jats:styled-content style=\"fixed-case\">TPMT<\/jats:styled-content>*<jats:styled-content style=\"fixed-case\">3A<\/jats:styled-content><\/jats:italic>and<jats:italic><jats:styled-content style=\"fixed-case\">TPMT<\/jats:styled-content>*<jats:styled-content style=\"fixed-case\">3C<\/jats:styled-content><\/jats:italic>) and inosine triphosphate pyrophosphatase (<jats:italic><jats:styled-content style=\"fixed-case\">ITPA<\/jats:styled-content>\u2010<\/jats:italic><jats:styled-content style=\"fixed-case\">C94A<\/jats:styled-content>), in<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>aucasian (<jats:italic>n<\/jats:italic>= 94, age &lt; 20) and Vietnamese (<jats:italic>n<\/jats:italic>= 141, age &lt; 16 years) childhood<jats:styled-content style=\"fixed-case\">ALL<\/jats:styled-content>and (b) to assess the impact of a multilocus genetic risk score (<jats:styled-content style=\"fixed-case\">MGRS<\/jats:styled-content>) on relapse\u2010free survival (<jats:styled-content style=\"fixed-case\">RFS<\/jats:styled-content>) using a Cox proportional\u2010hazards regression model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of<jats:italic><jats:styled-content style=\"fixed-case\">MTHFR<\/jats:styled-content>\u2010<\/jats:italic><jats:styled-content style=\"fixed-case\">677TT<\/jats:styled-content>genotype was significantly higher in<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>aucasians (<jats:italic>P<\/jats:italic>= 0.008), in contrast to the prevalence of<jats:italic><jats:styled-content style=\"fixed-case\">TYMS\u2010TSER<\/jats:styled-content>*<jats:styled-content style=\"fixed-case\">3R<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">3R<\/jats:styled-content><\/jats:italic>and<jats:italic><jats:styled-content style=\"fixed-case\">ITPA<\/jats:styled-content>\u2010<\/jats:italic><jats:styled-content style=\"fixed-case\">94AA<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">AC<\/jats:styled-content>genotypes which were significantly higher in<jats:styled-content style=\"fixed-case\">V<\/jats:styled-content>ietnamese (<jats:italic>P<\/jats:italic>&lt; 0.001 and<jats:italic>P<\/jats:italic>= 0.02, respectively). Compared with children with a low<jats:styled-content style=\"fixed-case\">MGRS<\/jats:styled-content>(\u22643), those with a high<jats:styled-content style=\"fixed-case\">MGRS<\/jats:styled-content>(\u22654) were 2.06 (95%<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>= 1.01, 4.22;<jats:italic>P<\/jats:italic>= 0.04) times more likely to relapse. Adding<jats:styled-content style=\"fixed-case\">MGRS<\/jats:styled-content>into a multivariate Cox regression model with race\/ethnicity and four clinical variables improved the predictive accuracy of the model (<jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content>from 0.682 to 0.709 at 24 months).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Including<jats:styled-content style=\"fixed-case\">MGRS<\/jats:styled-content>into a clinical model improved the predictive accuracy of short and medium term prognosis, hence confirming the association between well determined pharmacogenotypes and outcome of paediatric<jats:styled-content style=\"fixed-case\">ALL<\/jats:styled-content>. Whether variants on other genes associated with folate metabolism can substantially improve the predictive value of current<jats:styled-content style=\"fixed-case\">MGRS<\/jats:styled-content>is not known but deserves further evaluation.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.12481","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T10:37:48Z","timestamp":1407407868000},"page":"429-440","source":"Crossref","is-referenced-by-count":7,"title":["Comparative pharmacogenetic analysis of risk polymorphisms in<scp>C<\/scp>aucasian and<scp>V<\/scp>ietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?"],"prefix":"10.1111","volume":"79","author":[{"given":"Phuong Thu","family":"Vu Hoang","sequence":"first","affiliation":[{"name":"Centre de Technologies Mol\u00e9culaires Appliqu\u00e9es (CTMA) Institut de Recherche Exp\u00e9rimentale et Clinique (IREC) Universit\u00e9 catholique de Louvain (UCL) Brussels Belgium"},{"name":"Service d'h\u00e9matologie et oncologie p\u00e9diatrique Cliniques universitaires Saint\u2010Luc, Universit\u00e9 catholique de Louvain (UCL) Brussels Belgium"},{"name":"Pham Ngoc Thach University of Medecin Ho Chi Minh city Vietnam"},{"name":"Blood Transfusion and Hematology Hospital Ho Chi Minh city Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Ambroise","sequence":"additional","affiliation":[{"name":"Centre de Technologies Mol\u00e9culaires Appliqu\u00e9es (CTMA) Institut de Recherche Exp\u00e9rimentale et Clinique (IREC) Universit\u00e9 catholique de Louvain (UCL) Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne\u2010France","family":"Dekairelle","sequence":"additional","affiliation":[{"name":"Centre de Technologies Mol\u00e9culaires Appliqu\u00e9es (CTMA) Institut de Recherche Exp\u00e9rimentale et Clinique (IREC) Universit\u00e9 catholique de Louvain (UCL) Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Fran\u00e7ois","family":"Durant","sequence":"additional","affiliation":[{"name":"Centre de Technologies Mol\u00e9culaires Appliqu\u00e9es (CTMA) Institut de Recherche Exp\u00e9rimentale et Clinique (IREC) Universit\u00e9 catholique de Louvain (UCL) Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Butoescu","sequence":"additional","affiliation":[{"name":"Service d'Urologie Institut de Recherche Exp\u00e9rimentale et Clinique (IREC) Cliniques universitaires Saint\u2010Luc, Universit\u00e9 catholique de Louvain (UCL) Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu Luan","family":"Dang Chi","sequence":"additional","affiliation":[{"name":"Pham Ngoc Thach University of Medecin Ho Chi Minh city Vietnam"},{"name":"Blood Transfusion and Hematology Hospital Ho Chi Minh city Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nghia","family":"Huynh","sequence":"additional","affiliation":[{"name":"Blood Transfusion and Hematology Hospital Ho Chi Minh city Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tan Binh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Pham Ngoc Thach University of Medecin Ho Chi Minh city Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Robert","sequence":"additional","affiliation":[{"name":"P\u00f4le d'\u00e9pid\u00e9miologie et Biostatistique Institut de Recherche Exp\u00e9rimentale et Clinique (IREC) Universit\u00e9 catholique de Louvain (UCL) Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Vermylen","sequence":"additional","affiliation":[{"name":"Service d'h\u00e9matologie et oncologie p\u00e9diatrique Cliniques universitaires Saint\u2010Luc, Universit\u00e9 catholique de Louvain (UCL) Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Luc","family":"Gala","sequence":"additional","affiliation":[{"name":"Centre de Technologies Mol\u00e9culaires Appliqu\u00e9es (CTMA) Institut de Recherche Exp\u00e9rimentale et Clinique (IREC) Universit\u00e9 catholique de Louvain (UCL) Brussels Belgium"},{"name":"Defence Laboratories Department Belgian Armed Forces Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,2,20]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20073"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1800"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.moh.0000231424.46148.f9"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1251-4"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02626"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60457-2"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.12.1485"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2606"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4544"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.A10418"},{"key":"e_1_2_9_12_1","first-page":"227","article-title":"Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer","volume":"18","author":"Bedewy AM","year":"2013","journal-title":"J BUON"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200309000-00006"},{"key":"e_1_2_9_14_1","first-page":"1113","article-title":"Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia","volume":"91","author":"Costea I","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-6"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0169"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22292"},{"key":"e_1_2_9_18_1","first-page":"191","article-title":"Cyclin DI genetic polymorphism and clinical presentation of childhood acute lymphoblastic leukemia","volume":"8","author":"Pakakasama S","year":"2009","journal-title":"Australasian J Cancer"},{"key":"e_1_2_9_19_1","first-page":"2423","article-title":"Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma\u2010glutamyl hydrolase activity","volume":"8","author":"Panetta JC","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_9_20_1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0026-895X(24)13274-9","article-title":"Characterization of human cellular gamma\u2010glutamyl hydrolase","volume":"53","author":"Rhee MS","year":"1998","journal-title":"Mol Pharmacol"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.30.839"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02071.x"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.07.009"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.11.027"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.02.011"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705330"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-012-0395-2"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500224"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2012.44"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2014.10"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.792336"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4941"},{"key":"e_1_2_9_33_1","first-page":"11","article-title":"Frequency of C677T polymorphism of methylene tetrahyrofolate reductase (MTHFR) gene among Berber and Arabic Moroccan populations","volume":"20","author":"Paluku They\u2010They THK","year":"2009","journal-title":"Antropo"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdp.2008.02.004"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(88)90458-4"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08065-0"},{"key":"e_1_2_9_37_1","first-page":"2538","article-title":"Comparison of thymidylate synthase (TS) protein up\u2010regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues","volume":"6","author":"Welsh SJ","year":"2000","journal-title":"Clin Cancer Res"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-1004(200012)16:6<528::AID-HUMU11>3.0.CO;2-W"},{"key":"e_1_2_9_39_1","first-page":"651","article-title":"Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity","volume":"32","author":"Weinshilboum RM","year":"1980","journal-title":"Am J Hum Genet"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199510000-00003"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199608000-00001"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91745-V"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.69.5.577"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83063-X"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92400-7"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1996.15.17"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-8-199704150-00003"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90152-1"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.2.367"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20947"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488406784111627"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.21.332"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702152"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03867.x"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.154"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740330903426151"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.219"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045558"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-299"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000062"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2004.255"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.06.079"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-1353-0"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2000.00337.x"},{"key":"e_1_2_9_65_1","unstructured":"R Development Core Team.R: a language and environment for statistical computing 2005. Available athttp:\/\/www.R\u2010project.org(last accessed 27 August 2014)."},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880018.2012.657767"},{"key":"e_1_2_9_67_1","first-page":"353","article-title":"Thymidylate synthase gene polymorphism and its association with relapse in childhood B\u2010cell precursor acute lymphoblastic leukemia","volume":"88","author":"Lauten M","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_9_68_1","doi-asserted-by":"crossref","unstructured":"LuY KhamYKS HanyA TanAM QuahTC Juh YeohAE.Host pharmacogenetic factors significantly contribute to refinement of prognosis in children with Acute Lymphoblastic Leukemia (ALL): result from the Malaysia\u2010Singapore (Ma\u2010Spore) ALL 2003 Study.ASH.2011.","DOI":"10.1182\/blood.V118.21.567.567"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.12481","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.12481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:00:08Z","timestamp":1746327608000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.12481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,20]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1111\/bcp.12481"],"URL":"https:\/\/doi.org\/10.1111\/bcp.12481","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"type":"print","value":"0306-5251"},{"type":"electronic","value":"1365-2125"}],"subject":[],"published":{"date-parts":[[2015,2,20]]}}}